Pre-symptomatic diagnosis in ALS

Autor: Cécile Cazeneuve, P. Corcia, Patrick Vourc'h, K Mouzat, William Camu, Serge Lumbroso
Přispěvatelé: Centre de compétence de la Sclérose Latérale Amyotrophique [CHRU Tours] (SLA CHRU Tours), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Imagerie et cerveau (iBrain - Inserm U1253 - UNIV Tours ), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Laboratoire de Chimie BioOrganique / Université de Nîmes (LCBO), Université de Nîmes (UNIMES), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre référent Sclérose Latérale Amyotrophique [CHRU Montpellier] (SLA CHRU Montpellier), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Jazyk: angličtina
Rok vydání: 2020
Předmět:
DNA Mutational Analysis
MESH: Molecular Diagnostic Techniques
Gene mutation
medicine.disease_cause
Bioinformatics
0302 clinical medicine
Gene Frequency
C9orf72
MESH: Early Diagnosis
Medicine
030212 general & internal medicine
Amyotrophic lateral sclerosis
MESH: DNA Mutational Analysis
MESH: Confidentiality
MESH: Amyotrophic Lateral Sclerosis
MESH: Genetic Association Studies
Mutation
medicine.diagnostic_test
MESH: Genetic Testing
MESH: Genetic Predisposition to Disease
3. Good health
Molecular Diagnostic Techniques
Neurology
MESH: Disclosure
MESH: Genetic Counseling
Confidentiality
Prodromal Symptoms
Presymptomatic
Genetic Counseling
Disclosure
MESH: Asymptomatic Diseases
TARDBP
03 medical and health sciences
Genetic
MESH: Gene Frequency
Humans
Dementia
Genetic Predisposition to Disease
Genetic Testing
MESH: Prodromal Symptoms
Genetic Association Studies
Genetic testing
MESH: Humans
business.industry
[SCCO.NEUR]Cognitive science/Neuroscience
Amyotrophic Lateral Sclerosis
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Molecular biology

Genetic Status
medicine.disease
Early Diagnosis
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
Asymptomatic Diseases
Counselling
Neurology (clinical)
business
030217 neurology & neurosurgery
Zdroj: Revue Neurologique
Revue Neurologique, Elsevier Masson, 2020, 176 (3), pp.166-169. ⟨10.1016/j.neurol.2019.07.027⟩
ISSN: 0035-3787
DOI: 10.1016/j.neurol.2019.07.027⟩
Popis: International audience; Pathophysiology of amyotrophic lateral sclerosis (ALS) remains partially understood even though it is accepted worldwide that motor neuron death results from a pluri-factorial process with a variable role of genetic factors. Although not distinguishable from a clinical point of view, familial forms of ALS (fALS, 10% of cases) and sporadic forms (sALS, 90% of cases) can be described. Since the identification of superoxide dismutase 1 gene (SOD1) mutations, more than 30 genes have been linked to fALS. Among these genes, five (C9ORF72, SOD1, TARDBP, FUS, TBK1) seem predominant with mutation frequencies of 40%, 20%, 5%
Databáze: OpenAIRE